TipRanks
Go Ultimate55% OFF

Coherus Biosciences (CHRS) Balance Sheet

Coherus Biosciences Balance Sheet

Coherus Biosciences's total assets for Q2 2026 were $191.18M, a decrease of 28.13% from the previous quarter. CHRS total liabilities were $130.34M for the fiscal quarter, a 30.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 258.34M$ 448.53M$ 629.60M$ 480.85M$ 679.33M
$ 197.33M$ 580.52M$ 823.03M$ 618.26M$ 581.61M
$ 61.01M$ -131.99M$ -193.43M$ -137.42M$ 97.73M

Currency in USD

Coherus Biosciences Debt to Assets

0300M600M900M60 %90 %120 %150 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets